igg4 subclass glutamic acid decarboxylase antibodies (gada...
TRANSCRIPT
![Page 1: IgG4 subclass glutamic acid decarboxylase antibodies (GADA ...lup.lub.lu.se/search/ws/files/8064101/1524341.pdfGADA was identified using commercially available enzyme linked immunosorbent](https://reader033.vdocument.in/reader033/viewer/2022041823/5e5fb014b305391a77592512/html5/thumbnails/1.jpg)
LUND UNIVERSITY
PO Box 117221 00 Lund+46 46-222 00 00
IgG4 subclass glutamic acid decarboxylase antibodies (GADA) are associated with areduced risk of developing type 1 diabetes as well as increased C-peptide levels inGADA positive gestational diabetes.
Dereke, Jonatan; Nilsson, Charlotta; Strevens, Helena; Landin-Olsson, Mona; Hillman,MagnusPublished in:Clinical Immunology
DOI:10.1016/j.clim.2015.11.001
2016
Document Version:Peer reviewed version (aka post-print)
Link to publication
Citation for published version (APA):Dereke, J., Nilsson, C., Strevens, H., Landin-Olsson, M., & Hillman, M. (2016). IgG4 subclass glutamic aciddecarboxylase antibodies (GADA) are associated with a reduced risk of developing type 1 diabetes as well asincreased C-peptide levels in GADA positive gestational diabetes. Clinical Immunology, 162, 45-48.https://doi.org/10.1016/j.clim.2015.11.001
General rightsCopyright and moral rights for the publications made accessible in the public portal are retained by the authorsand/or other copyright owners and it is a condition of accessing publications that users recognise and abide by thelegal requirements associated with these rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private studyor research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portalTake down policyIf you believe that this document breaches copyright please contact us providing details, and we will removeaccess to the work immediately and investigate your claim.
![Page 2: IgG4 subclass glutamic acid decarboxylase antibodies (GADA ...lup.lub.lu.se/search/ws/files/8064101/1524341.pdfGADA was identified using commercially available enzyme linked immunosorbent](https://reader033.vdocument.in/reader033/viewer/2022041823/5e5fb014b305391a77592512/html5/thumbnails/2.jpg)
1
IgG4subclassGlutamicaciddecarboxylaseantibodies(GADA)areassociatedwithareducedriskofdevelopingtype1diabetesaswellasincreasedC-peptidelevelsinGADApositivegestationaldiabetesJonatanDerekeMSc1,CharlottaNilssonMDPhD1,2,HelenaStrevens,MD,PhD4,MonaLandin-OlssonMDPhD1,3andMagnusHillmanPhD1*.
1.LundUniversity,DepartmentofClinicalSciences,DiabetesResearchLaboratory,Lund,Sweden
2.HelsingborgHospital,DepartmentofPediatrics,Helsingborg,Sweden
3.SkåneUniversityHospitalLund,DepartmentofEndocrinology,Lund,Sweden
4.SkåneUniversityHospitalLund,DepartmentofObstetrics,LundSweden.
*Correspondingauthor:MagnusHillman,B11,BMC,22184Lund,Sweden,[email protected],Phone:+46462220704.
Keywords:Gestationaldiabetesmellitus,Glutamicaciddecarboxylaseantibodies,Type1diabetes,IgGsubclasses.Shorttitle:GADAIgG4ingestationaldiabetesmellitus.Wordsinabstract:149Wordsinmanuscript:2618
Authorse-mailaddresses:[email protected];[email protected];[email protected];[email protected];[email protected]
![Page 3: IgG4 subclass glutamic acid decarboxylase antibodies (GADA ...lup.lub.lu.se/search/ws/files/8064101/1524341.pdfGADA was identified using commercially available enzyme linked immunosorbent](https://reader033.vdocument.in/reader033/viewer/2022041823/5e5fb014b305391a77592512/html5/thumbnails/3.jpg)
2
AbstractSomewomenwithgestationaldiabetes(GDM)presentwithautoantibodiesassociatedwithtype1diabetes.Theseareusuallydirectedagainstglutamicaciddecarboxylase(GADA)andsuggestedtopredictdevelopmentoftype1diabetes.TheprimaryaimofthisstudywastoinvestigateifGADAIgGsubclassesatonsetofGDMcouldassistinpredictingpostpartumdevelopment.Of1225womendiagnosedwithfirst-timeGDMonly51wereGADA-positive.TotalGADAwasdeterminedusingELISA.GADAsubclassesweredeterminedwithradioimmunoassay.Approximately25%ofGADA-positivewomendevelopedtype1diabetespostpartum.TitersoftotalGADAwerehigherinwomenthatdevelopedtype1diabetes(142.1vs74.2u/mL;p=0.04)andtheyalsohadlowertitersofGADAIgG4(index=0.01vs0.04;p=0.03).InconclusionwefoundthatthatwomenwithhightitersoftotalGADAbutlowtitersofGADAIgG4weremorepronetodeveloptype1diabetespostpartum.
![Page 4: IgG4 subclass glutamic acid decarboxylase antibodies (GADA ...lup.lub.lu.se/search/ws/files/8064101/1524341.pdfGADA was identified using commercially available enzyme linked immunosorbent](https://reader033.vdocument.in/reader033/viewer/2022041823/5e5fb014b305391a77592512/html5/thumbnails/4.jpg)
3
IntroductionGestationaldiabetesmellitus(GDM)isaheterogeneousdisorderaffectingapproximately2.5%ofpregnantwomeninsouthernSweden.Afewpercentofthesewomeninturnpresentwithantibodiestargetingisletspecificantigens,glutamicaciddecarboxylaseantibodies(GADA)inparticular[1-3].ThepresenceofGADAatonsetofGDM[4]oratdelivery[1]hasbeensuggestedtopredictfuturedevelopmentoftype1diabetes.
Type1diabetesisconsideredtobeacellularTh1/Th17mediateddisease.TheexactmechanismsaredebatedbutthetopicconcerningTcellsubsets,toleranceinterferenceandpost-translationalmodificationsofantigensiscomprehensivelyreviewedbyHaskinsandCook[5].Theadaptiveimmunesystemduringpregnancy,however,ispolarizedtowardsahumoralTh2response[6].InsettingdominatedbyTh1/Th17cells,thelocalcytokineprofilewillinduceanisotypeswitchtowardsthehumanIgG1subclass[7,8],whileTh2cellswillinduceanisotypeswitchtowardsthehumanIgG4subclass[9].Whetherthisactuallymaypreventtype1diabetesornotwillneedtobefurtherinvestigatedinfuturestudies,butpromisingresultshavebeenshowninNODmice[10,11].
Wehavepreviouslyshownthatpatientswithlatentautoimmunediabetesinadults(LADA)haveahigherfrequencyofGADAIgG4antibodiescomparedtopatientswithadultonsettype1diabetes[12].WehavesuggestedthattheTh1andTh2balancewithinpancreaticbetacellsmaybedifferentbetweenpatientswithtype1diabetesandLADAsincetheIgG4isotypeswitchismediatedmainlybyTh2cytokines.ThusitseemsreasonabletohypothesizethatalsoGADApositivewomenwithGDMcouldhavehighertitersofGADAIgG4antibodies.OnlyonestudyhaspreviouslyreportedGADAreactivity,includingGADAIgG1andIgG4,aswellasepitopebindingduringGDM[13].TheGADAIgG4positivitywasreportedtobe44%,whileGADAIgG1positivitywasashighas76%inthe34womenwithGDM.TheauthorscouldnotfindadifferenceincirculatingGADAIgGsubclassesbetweenpatientswithtype1diabetesandGDM,althoughareducedandmorerestrictedantibodyresponsewassuggestedduetolesserepitopespreadinginpatientswithGDM.
TheassociationbetweentheHLA-regionatchromosome6andautoimmunediabeteshasbeenknownformorethanthreedecades[14]andwhilecertainvariantsoftheDQbetachainencodessusceptibilitymotifs(DQB1*0201andDQB1*0302andalsoknownasDQ2andDQ8respectively),othersareprotective(DQB1*0602)[15].BothDQB1*0201andDQB1*0302arereportedinonestudytobeslightlymorecommoninScandinavianwomenwithGDMcomparedtoinpregnantcontrols[16].ThepresenceofGADAwasespeciallyassociatedwithDQB1riskgenotypesinthisstudy.AnotherstudysuggestedtheprotectivegenotypetobelessfrequentinGDMpatientsbutwithoutbeingabletoconfirmanincreasedfrequencyofhighriskgenotypes[17].AthirdstudyinvestigatedHLAriskallelesinautoantibodypositivewomenwithGDMandconcludedthattherewasanassociationwithautoantibodiesandthedevelopmentoftype1diabetespostpartum[18].
OuraimwiththisstudywastoinvestigateifGADAIgG1andIgG4subclassdistributioninwomenwithGDMisassociatedwiththeendogenousinsulinsecretionanddevelopmentoftype1diabetespostpartum.WewerealsointerestedinwhetherDQB1risktypes(DQ2andDQ8)couldbeassociatedwiththeGADAsubclassdistributionorcouldpredictthedevelopmentofmanifesttype1diabetespostpartuminourmaterial.
![Page 5: IgG4 subclass glutamic acid decarboxylase antibodies (GADA ...lup.lub.lu.se/search/ws/files/8064101/1524341.pdfGADA was identified using commercially available enzyme linked immunosorbent](https://reader033.vdocument.in/reader033/viewer/2022041823/5e5fb014b305391a77592512/html5/thumbnails/5.jpg)
4
Materialandmethods
ParticipantsWomendiagnosedwithnew-onsetGDMatSkåneUniversityHospitalinLund,Sweden,1996-2013(n=1225)wereaskedtoparticipateinthesestudies.Allwomenconsentedandwerescreenedforautoantibodies.CriteriaforGDMdiagnosiswerebloodglucosevaluesof≥10mmol/Laftera2hour75goralglucosetolerancetest(OGTT).PatientswerefolloweduppostpartumtomakesurethatthepathologicalbloodglucosevaluewasnormalizedoraclassificationofmanifestdiabeteswasusedinsteadofGDM.AllGDMwomenareofferedfollow-upat3-monthto1-yearintervalspostpartum.
TheStudywasconductedinaccordancewiththeHelsinkideclarationandapprovedbytheRegionalEthicalReviewBoardatLundUniversity(LU526/00;849/2005;244/2007,2009/307and2014/78).
Bloodtests
BloodwasdrawninserumandEDTAplasmavialsandsenttothelaboratorybyhospitalpost.Plasmaandserumwasseparatedbycentrifugationat2000xgandstoredat-70°Cuntiluse.
DetectionofGADApositivity
GADAwasidentifiedusingcommerciallyavailableenzymelinkedimmunosorbentassay’s(ELISA)fromRSRLtdwithareportedspecificityandsensitivityof100%and90%respectively[19].AbsorbancewasmeasuredinaFLOUstarOptima(BMGLabtech).Thecut-offlevelforpositivitywassetat10u/ml.Atotalof53womenwerepositiveforGADA(4.3%)andwereincludedinthestudy.SerumorEDTAplasmawasavailablefrom51oftheGADApositivepatients
GADAIgG1andIgG4subclassesAliquidphasebindingradioimmunoprecipitationassay(LPBA)wasusedtodetectGADAIgG1andIgG4subclassesinGADApositivewomenasdescribedindetailelsewhere[20].Briefly,serumorplasmawasincubatedinduplicateswithrecombinant35S(Perkin-Elmer)-labeledGAD65,followedbyincubationwithanti-humanIgG1antibodies(15µg/ml,BDPharmingen)oranti-humanIgG4antibodies(25µg/ml,BDPharmingen)overnightat4°C,formingimmunecomplexesbetweenGADAandGAD65,aswellasbetweenhumanIgG-subclassesandmouseanti-humansubclassantibodies.Theimmunecomplexeswereprecipitatedontostreptavidinsepharose(40%dilution,GEhealthcare)in96-wellfilterplates(Millipore,France)pre-coatedwith1%BSAtoavoidunspecificbindingandpunchedoutintovialswith4mlscintillationfluid(UltimaGold,Perkin-Elmer).Countsperminute(cpm)weremeasuredinabeta-counter(PackardTri-carb2100TR)for2minutespersample.Quadraplicatesofin-housestandardswereusedandindexeswerecalculatedtoestimateIgG-subclasstiters.Anindexof0.04wasusedascut-offlevelforGADAIgG1positivityand0.03forGADAIgG4positivity[20].
C-peptideC-peptidelevelsweremeasuredwithcommerciallyavailableready-to-useELISAkits(Mercodia)accordingtomanufacturers’instructions.Internalcontrolswerealsopurchasedfromthesamemanufacturer.Thereporteddetectionlimitwas15pmol/landabsorbancewasmeasuredat450nminaFLOUstarOptima(BMGLabtech).
HLA-genotypingDNAwasextractedfromleukocyteswithasalt-outprecipitationmethod[21].Concentrationandpuritywasdeterminedbymeasuringtheratioofabsorbanceat260/280nm.HLA-DQβ1riskalleles(DQ2/DQ8)weredeterminedusingacommerciallyavailableMutaGEL®HLA-DQ2+8kit
![Page 6: IgG4 subclass glutamic acid decarboxylase antibodies (GADA ...lup.lub.lu.se/search/ws/files/8064101/1524341.pdfGADA was identified using commercially available enzyme linked immunosorbent](https://reader033.vdocument.in/reader033/viewer/2022041823/5e5fb014b305391a77592512/html5/thumbnails/6.jpg)
5
(immundiagnostikAG)withspecificprimersforHLADQ2(allelecombinationDQα1*05/DQβ1*0201)andHLA-DQ8(allelecombinationDQα1*03/DQβ1*0302).Allgenotypingwasperformedaccordingtothemanufacturers’instructions.
StatisticalanalysesDistributionofdatawasestimatedusingD’Agostino-Pearsontest[22].Resultsarereportedasmean±standarddeviationfordatathatfollowedanormaldistributionandmedianfollowedbyinterquartilerange(IQR)inbracketswhennormaldistributionwasrejected.The2-tailedMann-WhitneyU-testwasusedtoanalyzedifferencesinIgG-subclasstitersbetweenthetwogroupsandtheWilcoxonsignedranktesttocompareIgG-subclasstitersbetweenthefirstandsecondpregnancywithGDM.TheSpearmanrankcorrelationwasusedtodetectassociationsbetweenantibodiesand/orC-peptidelevels.Fischer’sexacttestwasusedtotestfordifferencesinfrequencyofGADAIgG-subclasspositivityinthegroups.P<0.05wasconsideredtobestatisticallysignificant.ThestatisticalsoftwareMedCalcforWindows®v.14.12.0wasusedtoanalyzethedata.
ResultsClinicalandlaboratorydataarepresentedintable1.Atotalof53ofthe1225GDMwomenwerepositiveforGADA(4.3%)andserumorEDTAplasmawasavailablefrom51oftheGADApositiveGDMwomenforIgGsubclassanalyses.ThetwowomenwithoutavailableserumorEDTAplasmasampleswereexcludedfromthestudy.Neitheroneofthesetwowomenwerereportedtohavedevelopedmanifestdiabetesduringfollow-up.AllGADApositiveGDMwomenparticipatedinfollow-upatregular3-monthto1-yearintervals.Twelveofthe51GDMwomenwithGADApositivityincludedinthestudydevelopedtype1diabeteswithin0-5yearsafteronsetofGDM(1.4±1.1years).SomeoftheGADApositivewomen(n=15)returned,duringtheirsecondpregnancywithGDM,1-9yearsafterpostpartum(4.5±2.8years).TwoofthemalsohadathirdpregnancywithGDMwithintwoyearsafterthesecond.
TotalGADAtitersweresignificantlyhigherinpatientsthatdevelopedtype1diabetes;142.1(61.6-821.5)u/ml,comparedtoinpatientsthatdidnot;74.2(30.1-227.8)u/ml(p=0.04).
TheGADAIgG4titers,tothecontrary,weresignificantlylowerinwomenthatdevelopedtype1diabetes(p=0.03)andthefrequencyofGADAIgG4positivitywassignificantlydecreasedinthisgroup(Fig1,p=0.04).NosignificantdifferencesoftheGADAIgG1levelswerefoundbetweenthegroups.
AllpatientspositiveforGADAIgG4werealsopositiveforGADAIgG1.However,positivityforGADAIgG1wastwiceasfrequentasGADAIgG4inourmaterialwithfrequenciesof82%(42/51)and41%(21/51)respectively.TotalGADAcorrelatedsignificantlywithGADAIgG1(rs=0.65;p<0.0001)butnotwithGADAIgG4(rs=0.11;p=0.47).
C-peptidelevelswerenotsignificantlydifferentbetweenwomenwhodevelopedtype1diabetes;1.09(0.42-1.40)nmol/Landwomenwhodidnot;1.35(0.64-1.90)nmol/L.However,apositivecorrelationwasfoundbetweenC-peptidelevelsandGADAIgG4(Fig2;rs=0.32;p=0.04).TherewasnosuchcorrelationbetweenC-peptideandGADAIgG1(rs=-0.03;p=0.86).
WomenwithGDMduringtheirsecondpregnancy(n=15),andinafewcasesalsotheirthirdpregnancy(n=2),retainedtheirGADAlevelsaswellastheirIgGsubclassprofile.Onlyoneofthewomen,withverylowlevelsoftotalGADA,IgG1andIgG4atclinicalonset,inherfirstpregnancy,turnedouttobeGADAnegativeduringhersecondpregnancywithGDM.
Inourmaterial15womenwerepositivefortheinvestigatedHLAriskallelesDQ2(n=7),DQ8(n=6)orboth(n=2).NostatisticallysignificantincreaseoftheanalyzedHLAriskalleleswasfoundinwomen
![Page 7: IgG4 subclass glutamic acid decarboxylase antibodies (GADA ...lup.lub.lu.se/search/ws/files/8064101/1524341.pdfGADA was identified using commercially available enzyme linked immunosorbent](https://reader033.vdocument.in/reader033/viewer/2022041823/5e5fb014b305391a77592512/html5/thumbnails/7.jpg)
6
whodevelopedtype1diabetes.However,GADAIgG4positivewomenhadasignificantlylowerfrequencyofDQ2or8(2/21;11%,bothbeingDQ8)comparedtoGADAIgG4negativepatients(13/30;43%;p=0.012).Also,womenwiththeDQ2genotype(n=9)hadhigherlevelsofGADA;240.6(132.1-816.7)u/mLcomparedtoinwomenwithoutDQ2(n=42);74.3(48.7-140.5)u/mL,althoughthiswasnotstatisticallysignificant(p=0.07).
DiscussionOurmainfindingwasthatnotonlyGADApositivityinitself,butalsoGADAsubclassdistributioncouldinfluencetheriskofdevelopingtype1diabetespostpartum.GADApositivewomenwithGDMandhighertitersofGADAIgG4werelesspronetodeveloptype1diabetes,regardlessofGADAtiters.WealsofoundapositivecorrelationbetweenGADAIgG4andendogenousinsulinsecretion,asreflectedbytheC-peptidelevels,whichseemedtobehigherinIgG4positivewomen.
OnestrengthofthisstudyisthatitwasconductedinaregionofSweden,whereascreeningprogramforGDMincludesallpregnantwomen.AnOGTTisofferedtoallpregnantwomenat28weeksofgestationandalsoasearlyasthe12thweekofgestationinthecaseofknownriskfactors.TheseincludeapreviousGDM,1stdegreerelativewithdiabetesorBMI>30.
VirtuallyallwomenintheregionaccepttheofferofOGTT.ThereforepracticallyallpregnancieswithGDMaredetected.AlimitationofthestudyistherelativelysmallnumberofparticipantsduetothelowamountofGADApositivewomenwithGDM.TheassociationbetweenC-peptideandGADAIgG4
antibodiesmustbeinterpretedwithcautionduetothesmallnumberofpatients.
InourmaterialGADAIgG1positivitywastwiceasfrequentasGADAIgG4positivitywithfrequenciesof82%and41%respectively.ThesefiguresarewellinaccordancewithanotherGDMstudyreportingfrequenciesof76%and44%respectively[13].However,theauthorsalsoreportedpresenceofGADAIgG4inpatientswithtype1diabetes,whichwehavenotyetourselvesobservedintwopreviousGADAstudiesinadultpatients[12,23].Thisdiscrepancycouldbeduetodifferencesinmethodologyanddeterminationofthecut-offlevelsforpositivityineachIgG-subclass.
TherewasnodifferenceinGADAIgG1levelsbetweenpatientsthatdevelopedtype1diabetespostpartumandthosewhodidnot.ThissuggeststhatthecytotoxicTcellresponseinTh1/Th17cellsaresimilarinbothgroupsofwomen,butmightbebetterregulatedwithTh2cellspresentinthepatientswithoutdevelopmentoftype1diabetes.Mostofthewomenwhodevelopedtype1diabetespresentedwithinthefirsttwoyearspostpartum.OneGADAIgG4positivewomanwithGDMdidactuallydeveloptype1diabetes(Fig2).Although,notuntilfiveyearspostpartum,whichsuggeststhatthepresenceofTh2cellcytokines-asreflectedbytheIgG4subclass-inpancreaticlymphoidtissuesmightslowdownthebetacelldestruction.
Autoantibodypositivity,especiallyGADApositivity,hasbeenimpliedasariskfactorforthedevelopmentoftype1diabetespostpartuminseveralstudies[1-4]GADAtitersinwomenwithGDMhavenotyetassembledsuchinterest.However,inLADApatientsGADAtitershavebeenreportedtobeofprognosticvalueforbetacellfunction[24-26],whichmakesitreasonabletoassumethatthiswouldbethecasealsoinGADApositivewomenwithGDM.InmostcasestherewasagoodcorrelationbetweentotalGADAandGADAIgG1levels,suggestingthatIgG1isthemostabundantheavychaininthecirculationinGADApositivewomen.InsomewomenwithhightotalGADAbothGADAIgG1andIgG4werelowerthanexpected.ThiscouldbeduetohigherGADAIgMlevelsinthesesubjectsorthattheepitopesrecognizedbytheassaysaredifferent.
WhencomparingtitersoftotalGADAbetweenwomenwithandwithoutDQ2orDQ8nodifferenceswerefound.However,wedidfindatrendtowardshigherlevelsofGADAinwomenwiththeDQ2
![Page 8: IgG4 subclass glutamic acid decarboxylase antibodies (GADA ...lup.lub.lu.se/search/ws/files/8064101/1524341.pdfGADA was identified using commercially available enzyme linked immunosorbent](https://reader033.vdocument.in/reader033/viewer/2022041823/5e5fb014b305391a77592512/html5/thumbnails/8.jpg)
7
allelealone,whichalsoisinaccordancewiththeNIRADstudygroup’sreportonLADApatients.DQ2wasreportedtobemoreprevalentinthehigh-titerGADAgroupwhileDQ8wasequallydistributedbetweenhigh-andlow-titerGADApatientswithLADA[25].InourmaterialonlyonewomanwithDQ2andonlytwowomenwithDQ8werepositiveforGADAIgG4.Similarly,only11%(2/21)ofGADAIgG4positivewomenhadriskallelescomparedto43%(13/30)oftheGADAIgG4negativewomen.
PreviousstudiesonHLAriskallelesinGDMhavereportedthepresenceofGADAtobeassociatedwithDQriskgenotypesinScandinavianwomen[16].AfurtherstudyfoundnostatisticallysignificantassociationbetweenDQrisktypesandGDMbutinsteadthattheprotectivealleleDQB1*0602(DQ6)waslessfrequentinSwedishwomenwithGDM[17].Anexplanationtothesedifferentfindingscouldbethevaryinginclusioncriteriainthestudies.InourstudyonlyGADApositiveGDMwomenwereincluded,whichwouldexplainwhyDQrisktypesweremorecommoninthematerial.
GADApositivewomenwithmorethanoneGDMpregnancyretainedtheirGADApositiveandIgGsubclassprofileduringtheirsecondandthirdpregnancy,suggestingaremainingriskfordevelopmentoftype1diabetespostpartum,oftenwithintwoyearsafterclinicalonsetoftheirfirstGDM.
FuturestudiesshouldbeconductedinlargerpopulationsofGADApositivewomenwithGDMtofurtherinvestigatetheassociationbetweenC-peptideandIgGsubclasses.Moreinvestigationisrequiredbeforethisinformationmaybeusedforprognosticevaluationofresidualbeta-cellfunction.
InconclusionwefoundthatthatwomenwithGDMthathadhightitersofGADAweremorepronetodeveloptype1diabetespostpartum.However,presenceofGADAIgG4waspositivelycorrelatedwithC-peptidelevelsinourstudy,associatedwithalowerfrequencyofDQβ1riskallelesandreducedriskoftype1diabetes.
AcknowledgementsFundingfromTheSwedishDiabetesFoundationforDrMagnusHillmanandfromSkåneUniversityHospitalFundingandDonationsforDrMonaLandin-Olssonwereusedtosupportthestudy.MrsBirgitteEkholmisthankedforexcellenttechnicalassistanceintheresearchlaboratory.
ConflictofinterestTheauthorsdeclarenoconflictofinterest.
AuthorcontributionsJD:Laboratoryanalyses,compilationofdata,statisticalanalysesandwritingpartsofthemanuscript.CN:Reviewofmedicalrecordsforfollowupofmanifestdiabetesmellituspostpartum,ethicalapplication,criticallyreviewofthemanuscript.HS:Criticalreviewofthemanuscript,proofreading,languageandcollectionofbloodsamples.MLO:Partsofthestudydesign,ethicalapplicationandcollectionofbloodsamples.MH:Studydesign,ethicalapplication,methoddevelopment,compilationandinterpretationofdata,statisticalanalysesandwritingpartsofthemanuscript.
![Page 9: IgG4 subclass glutamic acid decarboxylase antibodies (GADA ...lup.lub.lu.se/search/ws/files/8064101/1524341.pdfGADA was identified using commercially available enzyme linked immunosorbent](https://reader033.vdocument.in/reader033/viewer/2022041823/5e5fb014b305391a77592512/html5/thumbnails/9.jpg)
8
Table1.Serumorplasmawasavailablefor51GADApositivewomenatclinicalonsetofGDM.Twelvewomendevelopedtype1diabeteswithin5yearspostpartum.Ageisreportedasmean±standarddeviation.AntibodytitersandC-peptidelevelsarereportedasmedianfollowedbyinterquartilerange.PresenceofHLA-DQ2(DQB1*0201)and/orHLA-DQ8(DQB1*0302)isgivenintotal.
Nopostpartumtype1diabetes
(n=38)
Type1diabetespostpartum
(n=13)P-value
Age(years) 31.8±5.3 31.4±5.0 0.80
TotalGADA(u/ml) 74.2(30.1-227.8) 142.1(61.6-821.5) 0.04
GADAIgG1(index) 0.16(0.04-0.41) 0.41(0.12-0.54) 0.19
GADAIgG4(index) 0.04(0.02-0.06) 0.01(0.00-0.03) 0.03
C-peptide(nmol/L) 1.35(0.64-1.90) 1.09(0.42-1.40) 0.23
HLADQ2/8(yes/no) 10/28(26.3%) 5/8(38.5%) 0.48
References
[1] FuchtenbuschM,FerberK,StandlE,ZieglerAG.Predictionoftype1diabetespostpartuminpatientswithGDMmellitusbycombinedisletcellautoantibodyscreening:aprospectivemulticenterstudy.Diabetes,1997;46:1459-67.
[2] WhittinghamS,ByronSL,TuomilehtoJ,ZimmetPZ,MyersMA,VidgrenGetal.Autoantibodiesassociatedwithpresymptomaticinsulin-dependentdiabetesmellitusinwomen.DiabetMed,1997;14:678-85.
[3] JärveläIY,JuutinenJ,KoskelaP,HartikainenA-L,KulmalaP,KnipMetal.GDMidentifieswomenatriskforpermanenttype1andtype2diabetesinfertileage:predictiveroleofautoantibodies.Diabetescare,2006;29:607-12.
[4] NilssonC,UrsingD,TörnC,AbergA,Landin-OlssonM.PresenceofGADantibodiesduringGDMmellituspredictstype1diabetes.Diabetescare,2007;30:1968-71.
[5] HaskinsK,CookeA.CD4Tcellsandtheirantigensinthepathogenesisofautoimmunediabetes.Currentopinioninimmunology,2011.
[6] ReinhardG,NollA,SchlebuschH,MallmannP,RueckerAV.ShiftsintheTH1/TH2balanceduringhumanpregnancycorrelatewithapoptoticchanges.BiochemBiophysResCommun,1998;245:933-8.
[7] BoumendjelA,TawkL,MalefijtRdeW,BoulayV,YsselH,PeneJ.IL-27inducestheproductionofIgG1byhumanBcells.EurCytokineNetw,2006;17:281-9.
[8] HummelshojL,RyderLP,PoulsenLK.Theroleoftheinterleukin-10subfamilymembersinimmunoglobulinproductionbyhumanBcells.ScandJImmunol,2006;64:40-7.
[9] TangyeSG,FergusonA,AveryDT,MaCS,HodgkinPD.IsotypeswitchingbyhumanBcellsisdivision-associatedandregulatedbycytokines.JImmunol,2002;169:4298-306.
[10] MorelPA,SrinivasM,TurnerMS,FuschiottiP,MunshiR,BaharIetal.GeneexpressionanalysisofdendriticcellsthatpreventdiabetesinNODmice:analysisofchemokinesandcostimulatorymolecules.JLeukocBiol,2011;90:539-50.
[11] Feili-HaririM,FalknerDH,MorelPA.RegulatoryTh2responseinducedfollowingadoptivetransferofdendriticcellsinprediabeticNODmice.EurJImmunol,2002;32:2021-30.
[12] HillmanM,TörnC,ThorgeirssonH,Landin-OlssonM.IgG4-subclassofglutamicaciddecarboxylaseantibodyismorefrequentinlatentautoimmunediabetesinadultsthanintype1diabetes.Diabetologia,2004;47:1984-9.
![Page 10: IgG4 subclass glutamic acid decarboxylase antibodies (GADA ...lup.lub.lu.se/search/ws/files/8064101/1524341.pdfGADA was identified using commercially available enzyme linked immunosorbent](https://reader033.vdocument.in/reader033/viewer/2022041823/5e5fb014b305391a77592512/html5/thumbnails/10.jpg)
9
[13] FuchtenbuschM,BonifacioE,LampasonaV,KnopffA,ZieglerA.ImmuneresponsestoglutamicaciddecarboxylaseandinsulininpatientswithGDM.Clinicalandexperimentalimmunology,2004;135:318-21.
[14] NerupJ,ChristyM,KromannH,PlatzP,RyderLP,ThomsenMetal.HLAandinsulin-dependentdiabetesmellitus.Postgraduatemedicaljournal,1979;55Suppl2:8-13.
[15] ToddJA,BellJI,McDevittHO.HLA-DQbetagenecontributestosusceptibilityandresistancetoinsulin-dependentdiabetesmellitus.Nature,1987;329:599-604.
[16] ShaatN,EkelundM,LernmarkA,IvarssonS,NilssonA,PerfektRetal.GenotypicandphenotypicdifferencesbetweenArabianandScandinavianwomenwithGDMmellitus.Diabetologia,2004;47:878-84.
[17] PapadopoulouA,LynchKF,ShaatN,NilssonA,LernmarkB,BerntorpKetal.Thetype1diabetesprotectiveHLADQB1*0602alleleislessfrequentinGDMmellitus.Diabetologia,2009;52:1339-42.
[18] FerberKM,KellerE,AlbertED,ZieglerAG.PredictivevalueofhumanleukocyteantigenclassIItypingforthedevelopmentofisletautoantibodiesandinsulin-dependentdiabetespostpartuminwomenwithGDM.JClinEndocrinolMetab,1999;84:2342-8.
[19] TornC,MuellerPW,SchlosserM,BonifacioE,BingleyPJ,LabsP.DiabetesAntibodyStandardizationProgram:evaluationofassaysforautoantibodiestoglutamicaciddecarboxylaseandisletantigen-2.Diabetologia,2008;51:846-52.
[20] HillmanM,TörnC,Landin-OlssonM.Determinationofglutamicaciddecarboxylaseantibodies(GADA)IgGsubclasses-comparisonofthreeimmunoprecipitationassays(IPAs).Clinicalandexperimentalimmunology,2007;150:68-74.
[21] MillerSA,DykesDD,PoleskyHF.AsimplesaltingoutprocedureforextractingDNAfromhumannucleatedcells.Nucleicacidsresearch,1988;16:1215.
[22] D'AgostinoR,PearsonES.Testsfordeparturefromnormality.Empiricalresultsforthedistributionsofb2and√b1.Biometrika,1973;60:613-22.
[23] HillmanM,TörnC,Landin-OlssonM,groupDs.Theglutamicaciddecarboxylase65immunoglobulinGsubclassprofilediffersbetweenadult-onsettype1diabetesandlatentautoimmunediabetesinadults(LADA)upto3yearsafterclinicalonset.Clinicalandexperimentalimmunology,2009;157:255-60.
[24] LohmannT,KellnerK,VerlohrenHJ,KrugJ,SteindorfJ,ScherbaumWAetal.TitreandcombinationofICAandautoantibodiestoglutamicaciddecarboxylasediscriminatetwoclinicallydistincttypesoflatentautoimmunediabetesinadults(LADA).Diabetologia,2001;44:1005-10.
[25] BuzzettiR,DiPietroS,GiaccariA,PetroneA,LocatelliM,SuraciCetal.HightiterofautoantibodiestoGADidentifiesaspecificphenotypeofadult-onsetautoimmunediabetes.DiabetesCare,2007;30:932-8.
[26] LiuL,LiX,XiangY,HuangG,LinJ,YangLetal.Latentautoimmunediabetesinadultswithlow-titerGADantibodies:similardiseaseprogressionwithtype2diabetes:anationwide,multicenterprospectivestudy(LADAChinaStudy3).DiabetesCare,2015;38:16-21.
![Page 11: IgG4 subclass glutamic acid decarboxylase antibodies (GADA ...lup.lub.lu.se/search/ws/files/8064101/1524341.pdfGADA was identified using commercially available enzyme linked immunosorbent](https://reader033.vdocument.in/reader033/viewer/2022041823/5e5fb014b305391a77592512/html5/thumbnails/11.jpg)
10
Figure1.GADAIgG4titersinwomenthatdevelopedtype1diabetes(n=13)comparedtoinwomenwithoutmanifesttype1diabetes(n=38;p=0.03).
Figure2.AsignificantcorrelationwasfoundbetweenendogenousinsulinsecretionandGADAIgG4subclassofantibodies(rs=0.32,p=0.04)whichsuggestsaprotectiveroleofGADAIgG4.
![Page 12: IgG4 subclass glutamic acid decarboxylase antibodies (GADA ...lup.lub.lu.se/search/ws/files/8064101/1524341.pdfGADA was identified using commercially available enzyme linked immunosorbent](https://reader033.vdocument.in/reader033/viewer/2022041823/5e5fb014b305391a77592512/html5/thumbnails/12.jpg)
![Page 13: IgG4 subclass glutamic acid decarboxylase antibodies (GADA ...lup.lub.lu.se/search/ws/files/8064101/1524341.pdfGADA was identified using commercially available enzyme linked immunosorbent](https://reader033.vdocument.in/reader033/viewer/2022041823/5e5fb014b305391a77592512/html5/thumbnails/13.jpg)